<DOC>
	<DOC>NCT00338052</DOC>
	<brief_summary>This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.</brief_summary>
	<brief_title>Study of Bleeding With Extended Administration of an Oral Contraceptive</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy women Age 2540 History of regular cycles Current or recent (within 2 months) users of hormonal contraceptives Contraindications for use of hormonal contraception Conditions which affect the absorption or metabolism of steroid hormones BMI &gt; 35</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Contraception</keyword>
</DOC>